Infectious Disease Clinics of North America volume 18, issue 4, P829-841 2004 DOI: 10.1016/j.idc.2004.07.002 View full text
|
|
Share
Thomas J. Marrie

Abstract: There are no data from proper studies to answer whether it is necessary to include antibiotics that are active against atypical pneumonia agents as part of the empiric therapy of CAP. Until such data are available, clinical judgment and severity of the pneumonic illness are the best guides to empiric antimicrobial therapy.